196 related articles for article (PubMed ID: 23430447)
1. Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk.
Jaiswal PK; Tripathi N; Shukla A; Mittal RD
Med Oncol; 2013 Jun; 30(2):509. PubMed ID: 23430447
[TBL] [Abstract][Full Text] [Related]
2. Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population.
Ben Wafi S; Kallel A; Ben Fradj MK; Sallemi A; Ben Rhouma S; Ben Halima M; Sanhaji H; Nouira Y; Jemaa R; Feki M
J Clin Lab Anal; 2018 Nov; 32(9):e22610. PubMed ID: 29959793
[TBL] [Abstract][Full Text] [Related]
3. Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians.
Kapahi R; Guleria K; Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR
Tumour Biol; 2015 Jun; 36(6):4223-34. PubMed ID: 25604142
[TBL] [Abstract][Full Text] [Related]
4. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study.
Al Balawi IA; Mir R; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1135-1143. PubMed ID: 29699375
[TBL] [Abstract][Full Text] [Related]
5. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
Song Y; Yang Y; Liu L; Liu X
Gene; 2019 May; 698():186-197. PubMed ID: 30849545
[TBL] [Abstract][Full Text] [Related]
6.
Mahajan D; Sambyal V; Uppal MS; Sudan M; Guleria K
Genet Test Mol Biomarkers; 2024 May; 28(5):176-188. PubMed ID: 38597641
[TBL] [Abstract][Full Text] [Related]
7. Impact of VEGFA promoter polymorphisms on esophageal cancer risk in North-West Indians: a case-control study.
Guleria K; Kaur S; Mahajan D; Sambyal V; Sudan M; Uppal MS
Genes Genomics; 2022 Aug; 44(8):923-936. PubMed ID: 35767183
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
Jaiswal PK; Goel A; Mandhani A; Mittal RD
Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624
[TBL] [Abstract][Full Text] [Related]
9. Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population.
Jaiswal PK; Singh V; Srivastava P; Mittal RD
Gene; 2013 Apr; 519(1):128-34. PubMed ID: 23403235
[TBL] [Abstract][Full Text] [Related]
10. Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis.
Chen CH; Ho CH; Kuan-Hua Huang S; Shen CH; Wu CC; Wang YH
Cytokine; 2020 Jul; 131():155112. PubMed ID: 32361400
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis.
Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
Genet Mol Res; 2011 Oct; 10(4):3674-88. PubMed ID: 22058001
[TBL] [Abstract][Full Text] [Related]
12. The Protective Effects of the VEGF -2578C>A and -1154G>A Polymorphisms Against Hypertension Susceptibility.
Kim YR; Hong SH
Genet Test Mol Biomarkers; 2015 Sep; 19(9):476-80. PubMed ID: 26154735
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis.
Deng ZC; Cao C; Yu YM; Ma HY; Ye M
Tumour Biol; 2014 Mar; 35(3):1805-11. PubMed ID: 24146275
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.
Jang MJ; Kim JW; Jeon YJ; Chong SY; Oh D; Kim NK
Int J Clin Oncol; 2013 Dec; 18(6):1032-41. PubMed ID: 23132736
[TBL] [Abstract][Full Text] [Related]
15. Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case-control study.
Rahoui J; Laraqui A; Sbitti Y; Touil N; Ibrahimi A; Ghrab B; Al Bouzidi A; Moussaoui Rahali D; Dehayni M; Ichou M; Zaoui F; Mrani S
Med Oncol; 2014 Sep; 31(9):193. PubMed ID: 25148899
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer.
Mishra K; Behari A; Kapoor VK; Khan MS; Prakash S; Agrawal S
J Gastroenterol Hepatol; 2013 Oct; 28(10):1678-85. PubMed ID: 23962084
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
[TBL] [Abstract][Full Text] [Related]
18. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.
Jang MJ; Jeon YJ; Kim JW; Cho YK; Lee SK; Hwang SG; Oh D; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E60-9. PubMed ID: 23169005
[TBL] [Abstract][Full Text] [Related]
19. Relationship between vascular endothelial growth factor -2578C > a gene polymorphism and lung cancer risk: a meta-analysis.
Zhao HL; Yu JH; Huang LS; Li PZ; Lao M; Zhu B; Ou C
BMC Med Genet; 2020 Jan; 21(1):17. PubMed ID: 31996156
[TBL] [Abstract][Full Text] [Related]
20. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians.
Singh V; Jaiswal PK; Mittal RD
Urol Oncol; 2014 Nov; 32(8):1209-14. PubMed ID: 25218484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
